Jenburkt Pharmaceuticals informs about board meeting

24 May 2021 Evaluate
Jenburkt Pharmaceuticals has informed that with reference to the Regulation 29(1) and 30 of SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015, a Meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, 02th June, 2021, at the Registered Office of the Company, to take on record the audited financial results for the quarter and financial year ended on 31st March 2021 and to consider recommendation of Dividend, if any. The Board will also consider a proposal to acquire a land in the state of Gujarat, to set up a modern pharmaceutical formulations manufacturing unit and authorize Director to take necessary steps in respect of the same; and to consider a proposal to begin on pilot scale to sell certain Healthcare products via digital marketing. With reference to letter no. JPL/CS/1690/2021 dated 31st March, 2020, submitted with the Exchange, on the same day, the notional trading window is closed from 1st April, 2021 up to 48 hours after the completion of Board Meeting scheduled on 2nd June, 2021.

The above information is a part of company’s filings submitted to BSE.



Jenburkt Pharma Share Price

1038.40 5.65 (0.55%)
30-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1830.20
Dr. Reddys Lab 1183.00
Cipla 1549.65
Lupin 2094.65
Zydus Lifesciences 887.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...